Pulsenmore (PLSM): Safe and Sound: Pulsenmore Brings Prenatal Ultrasound Home
About this episode
Dr. Elazar Sonnenschein discusses Pulsenmore's innovative home-use prenatal ultrasound technology.
Send us Fan Mail Dr. Elazar Sonnenschein, Founder and CEO of Pulsenmore Ltd. (Nasdaq and Tel Aviv: PLSM), joins host Tim Gerdeman and WTR equity research analyst James Kisner on this episode of the WTR Small-Cap Spotlight Podcast. Pulsenmore has built the first FDA De Novo–authorized, prescription home-use prenatal ultrasound, allowing expectant mothers to capture images on a handheld device for remote physician review. Sonnenschein walks through the company’s journey from concept to creating...
People in this episode
Host: Tim Gerdeman
Guest: Dr. Elazar Sonnenschein
Topics covered
- prenatal ultrasound
- health technology
- home healthcare
- investing
- startup journey
Keywords
- Pulsenmore
- prenatal ultrasound
- home healthcare
- FDA approval
- health technology
Mentioned in this episode
Organizations: Pulsenmore Ltd., Water Tower Research
Products: FDA De Novo–authorized, prescription home-use prenatal ultrasound
Places: Nasdaq, Tel Aviv, home
More episodes of WTR Small-Cap Spotlight
- LifeVantage (LFVN): Navigating CEO Transition and Positioning for the Next Phase of Growth
- First Phosphate (FRSPF): Building a G7-Backed North American LFP Battery Supply Chain
- Homerun Resources (HMRFF): Turning High-Purity Silica into a Strategic Materials Platform
- Kaltura (KLTR) Talking Heads: Kaltura Puts a Face on Enterprise AI
- WTR Circular Carbon Primer: 50 Overlooked Companies at an Inflection Point
- AIB Data Centers ( AIB): Power Play — AIB's Move from Bitcoin Hosting to AI Infrastructure
Explore listener stats, chart rankings, contacts and more on the WTR Small-Cap Spotlight podcast page.